PFM Health Sciences’s Henry Schein HSIC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$11.2M Sell
134,423
-18,691
-12% -$1.43M 0.96% 40
2026
Q1
$11.3M Buy
+153,114
New +$11.8M 1.03% 34
2021
Q1
Sell
-395,161
Closed -$26.4M 97
2020
Q4
$26.4M Sell
395,161
-7,149
-2% -$461K 0.93% 42
2020
Q3
$23.6M Buy
+402,310
New +$25.8M 1.09% 35

Other funds holding HSIC

PFM Health Sciences's HSIC Position: Q2 2026 in Review

PFM Health Sciences reduced its Henry Schein (HSIC) stake by 12% in Q2 2026, selling an estimated $1.43M and leaving 134,423 shares worth $11.2M. The position accounts for 0.96% of the portfolio, ranked #40.

PFM Health Sciences first reported a position in HSIC in Q3 2020 and has held it in 4 quarters since. The position peaked at $26.4M in Q4 2020. 562 funds tracked by Wall St. Rank hold HSIC as of Q2 2026.

  • PFM Health Sciences held 134,423 shares of Henry Schein worth $11.2M as of Q2 2026.
  • PFM Health Sciences sold 18,691 Henry Schein shares in Q2 2026, an estimated $1.43M.
  • Henry Schein made up 0.96% of PFM Health Sciences's portfolio in Q2 2026, its #40 holding.
  • PFM Health Sciences first reported a position in Henry Schein in Q3 2020 and has held it in 4 quarters since.
  • PFM Health Sciences's Henry Schein position peaked at $26.4M in Q4 2020.
  • 562 funds tracked by Wall St. Rank held Henry Schein as of Q2 2026.

Based on PFM Health Sciences's 13F filing for Q2 2026, filed 14 Aug 2026.